Biography

About Samuel

Samuel Lin brings deep expertise in commercial market access and strategic planning across both U.S. and EU markets. Over the course of his career, he has supported product planning from early through late stages, developed evidence generation strategies, and shaped pricing and reimbursement approaches for clients spanning oncology, immunology, and cardiometabolic diseases. He holds a PharmD from the Philadelphia College of Pharmacy at Saint Joseph’s University.

Back to leadership team
Authored Posts

Published works and authored insights

dte thumbnail
July 23, 2026
Direct-to-employer drug models: From niche access model to channel strategy
Discover the market forces driving direct-to-employer adoption and what makes therapies strong candidates for direct commercialization.